van Es-Johansson An

Director at CYTORI THERAPEUTICS, INC. · on record since May 18, 2026
Director at ADVENTRX PHARMACEUTICALS INC · on record since Dec 26, 2019
Director at NEWLINK GENETICS CORP · on record since Feb 18, 2021

Insider trading activity of van Es-Johansson An

Transactions on record: 30; since Dec 26, 2019

Open-market buys: 0

Open-market sells: 0

Companies traded: 3; last filing Jul 1, 2026

Figures computed from official regulatory filings — methodology.

Companies where van Es-Johansson An has traded

CYTORI THERAPEUTICS, INC.12 tx · Jul 1, 2026
ADVENTRX PHARMACEUTICALS INC7 tx · Dec 11, 2025
NEWLINK GENETICS CORP11 tx · Dec 13, 2024

Track record of van Es-Johansson An

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of van Es-Johansson An

Co-insiders of van Es-Johansson An

Hawkins Richard JADVENTRX PHARMACEUTICALS INC +2
McCracken Joseph SADVENTRX PHARMACEUTICALS INC +1
Alexander SarahNEWLINK GENETICS CORP
Andrews Ronald AsburyCYTORI THERAPEUTICS, INC.
Arm Douglas MCYTORI THERAPEUTICS, INC.
Bagnall MarkADVENTRX PHARMACEUTICALS INC
BARBERRY CORP /NY/ADVENTRX PHARMACEUTICALS INC

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
CYTORI THERAPEUTICS, INC.	Jul 1, 2026	Exercise	922	0.00 USD	—	SEC
CYTORI THERAPEUTICS, INC.	Jul 1, 2026	ExerciseD	-922	0.00 USD	—	SEC
CYTORI THERAPEUTICS, INC.	May 18, 2026	AwardD	3,686	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	May 18, 2026	AwardD	3,686	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 11, 2025	Award	40,000	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Aug 15, 2025	AwardD	297,794	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Feb 20, 2025	AwardD	40,122	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 16, 2024	Award	40,000	0.00 USD	$0	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-5,729	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-3,345	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-3,328	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-3,431	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-2,910	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	Other	-1,100	—	—	SEC
CYTORI THERAPEUTICS, INC.	Sep 12, 2024	AwardD	3,650	0.00 USD	$0	SEC
NEWLINK GENETICS CORP	Jun 7, 2024	AwardD	3,328	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Feb 26, 2024	AwardD	2,250	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 15, 2023	Award	22,500	0.00 USD	$0	SEC
NEWLINK GENETICS CORP	May 12, 2023	AwardD	3,345	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Feb 17, 2023	AwardD	20,182	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 15, 2022	AwardD	40,000	0.00 USD	$0	SEC
NEWLINK GENETICS CORP	May 9, 2022	AwardD	3,431	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 14, 2021	AwardD	40,000	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	May 27, 2021	AwardD	6,336	0.00 USD	$0	SEC
NEWLINK GENETICS CORP	May 24, 2021	Award	367	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
CYTORI THERAPEUTICS, INC.	Jul 1, 2026	Exercise	922	0.00 USD	—	SEC
CYTORI THERAPEUTICS, INC.	Jul 1, 2026	ExerciseD	-922	0.00 USD	—	SEC
CYTORI THERAPEUTICS, INC.	May 18, 2026	AwardD	3,686	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	May 18, 2026	AwardD	3,686	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 11, 2025	Award	40,000	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Aug 15, 2025	AwardD	297,794	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Feb 20, 2025	AwardD	40,122	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 16, 2024	Award	40,000	0.00 USD	$0	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-5,729	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-3,345	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-3,328	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-3,431	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-2,910	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	Other	-1,100	—	—	SEC
CYTORI THERAPEUTICS, INC.	Sep 12, 2024	AwardD	3,650	0.00 USD	$0	SEC
NEWLINK GENETICS CORP	Jun 7, 2024	AwardD	3,328	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Feb 26, 2024	AwardD	2,250	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 15, 2023	Award	22,500	0.00 USD	$0	SEC
NEWLINK GENETICS CORP	May 12, 2023	AwardD	3,345	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Feb 17, 2023	AwardD	20,182	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 15, 2022	AwardD	40,000	0.00 USD	$0	SEC
NEWLINK GENETICS CORP	May 9, 2022	AwardD	3,431	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 14, 2021	AwardD	40,000	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	May 27, 2021	AwardD	6,336	0.00 USD	$0	SEC
NEWLINK GENETICS CORP	May 24, 2021	Award	367	0.00 USD	$0	SEC